Results
1 -
10 of
19Z, Hagers Handbuch der Pharmazeutischen Praxis Host-Mediated Antitumor Activity Induced by Neocarzinostatin and Its Polymer-Conjugated Derivative SMANCS in Tumor-Bearing Mice, Neocarzinostatin Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative, Cancer Immunology, Immunotherapy Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis, Cancer Chemotherapy and Pharmacology Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride, Supportive Care in Cancer Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma, Journal of Gastroenterology Patients with severe liver cirrhosis followed up by L-[1-13C] phenylalanine breath test, Journal of Gastroenterology Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma, Journal of Gastroenterology A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma, Investigational New Drugs